Dubinion John H, Mi Zaichuan, Jackson Edwin K
Center for Clinical Pharmacology, 100 Technology Drive, Suite 450, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
J Pharmacol Exp Ther. 2006 Jun;317(3):1330-6. doi: 10.1124/jpet.106.101279. Epub 2006 Mar 14.
The purpose of this study was to test the hypothesis that renal sympathetic nerves modulate angiotensin II-induced renal vasoconstriction in kidneys from genetically hypertensive rats via Y1 receptors activating the Gi pathway. In isolated, perfused kidneys from spontaneously hypertensive rats, the naturally occurring renal sympathetic cotransmitter neuropeptide Y at 6 nM enhanced angiotensin II (0.3 nM)-induced changes in perfusion pressure by 47 +/- 7 mm Hg, and this effect was inhibited by BIBP3226 [N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)-methyl]-D-arginine amide)], a selective Y1 receptor antagonist (1 microM). We next examined whether periarterial nerve stimulation (5 Hz) enhances renal vascular responses to a physiological level of angiotensin II (100 pM). Kidneys were pretreated with prazosin (a selective alpha1-adrenoceptor antagonist) to block nerve stimulation-induced changes in perfusion pressure. In kidneys from spontaneously hypertensive rats, but not normotensive rats, periarterial nerve stimulation significantly augmented angiotensin II-induced changes in perfusion pressure (177 +/- 26% of response in absence of stimulation). BIBP3226, but not rauwolscine (a selective alpha2-adrenoceptor antagonist), abolished periarterial nerve stimulation-induced enhancement of angiotensin II-mediated renal vasoconstriction. Pretreatment of hypertensive animals with pertussis toxin 3 days prior to kidney perfusion significantly (p < 0.000001) decreased mean blood pressure (203 +/- 2 versus 145 +/- 6 mm Hg in nonpretreated versus pertussis toxin-pretreated spontaneously hypertensive rats) and abolished periarterial nerve stimulation-induced enhancement of angiotensin II-mediated renal vasoconstriction. We conclude that, in spontaneously hypertensive rats but not normotensive rats, sympathetic nerve stimulation enhances renal vascular responses to physiological levels of angiotensin II via a mechanism mainly involving Y1 receptors coupled to Gi proteins.
肾交感神经通过激活Gi途径的Y1受体,调节基因性高血压大鼠肾脏中血管紧张素II诱导的肾血管收缩。在来自自发性高血压大鼠的离体灌注肾脏中,6 nM的内源性肾交感神经共同递质神经肽Y使血管紧张素II(0.3 nM)诱导的灌注压变化增加了47±7 mmHg,而这种作用被选择性Y1受体拮抗剂BIBP3226 [N2-(二苯基乙酰基)-N-[(4-羟基苯基)-甲基]-D-精氨酸酰胺](1 μM)所抑制。接下来,我们研究了动脉周围神经刺激(5 Hz)是否增强肾脏对生理水平血管紧张素II(100 pM)的血管反应。用哌唑嗪(一种选择性α1肾上腺素能受体拮抗剂)预处理肾脏,以阻断神经刺激诱导的灌注压变化。在来自自发性高血压大鼠而非正常血压大鼠的肾脏中,动脉周围神经刺激显著增强了血管紧张素II诱导的灌注压变化(无刺激时反应的177±26%)。BIBP3226而非育亨宾(一种选择性α2肾上腺素能受体拮抗剂)消除了动脉周围神经刺激诱导的血管紧张素II介导的肾血管收缩增强作用。在肾脏灌注前3天用百日咳毒素预处理高血压动物,可显著(p < 0.000001)降低平均血压(未预处理的自发性高血压大鼠为203±2 mmHg,百日咳毒素预处理的自发性高血压大鼠为145±6 mmHg),并消除动脉周围神经刺激诱导的血管紧张素II介导的肾血管收缩增强作用。我们得出结论,在自发性高血压大鼠而非正常血压大鼠中,交感神经刺激通过主要涉及与Gi蛋白偶联的Y1受体的机制,增强了肾脏对生理水平血管紧张素II的血管反应。